1DHK image
Deposition Date 1996-10-14
Release Date 1997-12-24
Last Version Date 2024-10-23
Entry Detail
PDB ID:
1DHK
Title:
STRUCTURE OF PORCINE PANCREATIC ALPHA-AMYLASE
Biological Source:
Source Organism:
Sus scrofa (Taxon ID: 9823)
Phaseolus vulgaris (Taxon ID: 3885)
Method Details:
Experimental Method:
Resolution:
1.85 Å
R-Value Free:
0.22
R-Value Work:
0.18
R-Value Observed:
0.18
Space Group:
C 1 2 1
Macromolecular Entities
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:PORCINE PANCREATIC ALPHA-AMYLASE
Gene (Uniprot):AMY2
Chain IDs:A
Chain Length:496
Number of Molecules:1
Biological Source:Sus scrofa
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:BEAN LECTIN-LIKE INHIBITOR
Gene (Uniprot):LLP
Chain IDs:B
Chain Length:223
Number of Molecules:1
Biological Source:Phaseolus vulgaris
Modified Residue
Compound ID Chain ID Parent Comp ID Details 2D Image
ASN B ASN GLYCOSYLATION SITE
PCA A GLN PYROGLUTAMIC ACID
Primary Citation
Substrate mimicry in the active center of a mammalian alpha-amylase: structural analysis of an enzyme-inhibitor complex.
Structure 4 1441 1452 (1996)
PMID: 8994970 DOI: 10.1016/S0969-2126(96)00151-7

Abstact

BACKGROUND alpha-Amylases catalyze the hydrolysis of glycosidic linkages in starch and other related polysaccharides. The alpha-amylase inhibitor (alpha-Al) from the bean Phaseolus vulgaris belongs to a family of plant defence proteins and is a potent inhibitor of mammalian alpha-amylases. The structure of pig pancreatic alpha-amylase (PPA) in complex with both a carbohydrate inhibitor (acarbose) and a proteinaceous inhibitor (Tendamistat) is known, but the catalytic mechanism is poorly understood. RESULTS The crystal structure of pig pancreatic alpha-amylase complexed with alpha-Al was refined to 1.85 A resolution. It reveals that in complex with PPA, the inhibitor has the typical dimer structure common to legume lectins. Two hairpin loops extending out from the jellyroll fold of a monomer interact directly with the active site region of the enzyme molecule, with the inhibitor molecule filling the whole substrate-docking region of the PPA. The inhibitor makes substrate-mimetic interactions with binding subsites of the enzyme and targets catalytic residues in the active site. Binding of inhibitor induces structural changes at the active site of the enzyme. CONCLUSIONS The present analysis reveals that there are extensive interactions between the inhibitor and residues that are highly conserved in the active site of alpha-amylases; alpha-Al1 inactivates PPA through elaborate blockage of substrate-binding sites. It provides a basis to design peptide analogue inhibitors. alpha-Amylase inhibition is of interest from several points of view, for example the treatment of diabetes and for crop protection.

Legend

Protein

Chemical

Disease

Primary Citation of related structures